Author

Niranjan Sardesai

Observed names: N. Sardesai, Niranjan J. Sardesai, Sardesai Niranjan

Observed institutions: Bepress (United States), Plymouth City Council, Inovio Pharmaceuticals (United States), University of Pennsylvania

OpenAlex ID: A5113969927

Immunogenicity of Novel Consensus-Based DNA Vaccines Against Chikungunya Virus

2008 · K. Muthumani, K. Lankaraman, et al. · International Journal of Infectious Diseases · 13

PDF

453 Personalized DNA neoantigen vaccine (GNOS-PV02) in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma

2021 · Mark Yarchoan, Edward Gane, et al. · Regular and Young Investigator Award Abstracts · 9

PDF

Personalized DNA neoantigen vaccine in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma.

2021 · Mark Yarchoan, Edward Gane, et al. · Journal of Clinical Oncology · 9

692 Circulating tumor DNA analysis of advanced hepatocellular cancer (HCC) patients treated with neoantigen targeted personalized cancer DNA vaccine (GNOS-PV02) in combination with plasmid IL-12 (pIL12) and anti-PD1 (pembrolizumab)

2022 · Renzo Perales, Alfredo Perales-Puchalt, et al. · Regular and Young Investigator Award Abstracts · 5

PDF

DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

2014 · the HPV-003 Protocol team, Laurent Humeau, et al. · Journal for ImmunoTherapy of Cancer · 4

PDF

Ctim-33. Personalized Multivalent Dna Vaccination Safely Induces Broad Neoantigen-specific T Cell Responses in Newly Diagnosed Mgmt Unmethylated Glioblastoma in a Clinically Relevant Time Scale

2025 · Elizabeth Garfinkle, Renzo Perales-Linares, et al. · Neuro-Oncology · 1

PDF

A single immunization with optimized DNA vaccines protects against lethal Ebola virus challenge in mice (VAC8P.1057)

2015 · Ami Patel, Veronica Scott, et al. · The Journal of Immunology · 1

Cervical cancer immunotherapy: Induction of HPV specific CTLs in human volunteers after VGX-3100 immunization

2012 · Niranjan Sardesai · 1

Personalized DNA neoantigen vaccine in combination with plasmid IL-12 for the treatment of a patient with anaplastic astrocytoma.

2021 · Tanner Michael Johanns, Alfredo Perales-Puchalt, et al. · Journal of Clinical Oncology

Clinical and Immunologic Biomarkers for Regression of High Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 Infection after Immunotherapy with VGX-3100 in a Phase IIb Clinical Trial

2017 · Matthew P Morrow, Kimberly A Kraynyak, et al. · The Journal of Immunology

Unprecedented short-term in vivo protection in mice with a single immunization of a DNA GP vaccine against heterologous mouse-adapted Ebola virus challenge

2016 · Ami Patel, Trina Racine, et al. · The Journal of Immunology

479. An Optimized DNA Vaccine Formulation Protects Against Lethal Ebola Makona Virus Challenge in Non-Human Primates and Elicits Robust Immune Responses

2016 · Ami Patel, Emma L. Reuschel, et al. · Molecular Therapy

PDF

505. VGX-3100 Drives Regression of HPV16/18 CIN2/3 and Robust Cellular Immune Responses in Blood and Cervical Tissue in a Blinded, Randomized, Placebo-Controlled Phase 2B Study

2016 · Matthew Morrow, Connie Trimble, et al. · Molecular Therapy

PDF

Abstract CT131: HPV specific immunotherapy for cervical intraepithelial neoplasia using VGX-3100 induces regression of cervical lesions and potent T-cell responses: Results from a randomized, double-blind, placebo-controlled phase II study

2015 · Matthew Morrow, Cornelia Trimble, et al. · Cancer Research

HPV specific immunotherapy for cervical intraepithelial neoplasia using VGX-3100 induces regression of cervical lesions and potent T cell responses: results from a randomized, double-blind, placebo-controlled phase II study (VAC13P.1135)

2015 · Matthew Morrow, Cornelia Trimble, et al. · The Journal of Immunology

ITOC2 – 020. VGX-3100 Immunotherapy for CIN2/3 Induces regression of cervical lesions and viral clearance (Phase II study): Implications for treatment of HPV associated cancers

2015 · Sardesai Niranjan, Trimble Cornelia, et al. · European Journal of Cancer

G-109 Reverse vaccinology identified promising vaccine candidates focusing responses to relatively conserved regions associated with control of viremia

2014 · Barbara Felber, Xintao Hu, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes

A Novel T-cell Vaccine Eliciting T-cell Specificities Associated with Control of HIV-1 In Humans Is Highly Immunogenic in Mice and Macaques

2014 · Beatriz Mothe, Xintao Hu, et al. · AIDS Research and Human Retroviruses

PDF

Works count: 20

Citation count: 43

H-index: 4

I10-index: 1